• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非对称性二甲基精氨酸加剧与脑血管病变相关的认知功能障碍。

Asymmetric dimethylarginine exacerbates cognitive dysfunction associated with cerebrovascular pathology.

机构信息

Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.

Research Service, Ralph H. Johnson Veterans Administration Medical Center, Charleston, SC, USA.

出版信息

FASEB J. 2020 May;34(5):6808-6823. doi: 10.1096/fj.201901318R. Epub 2020 Apr 2.

DOI:10.1096/fj.201901318R
PMID:32239698
Abstract

Asymmetric dimethylarginine (ADMA), an endogenous inhibitor and uncoupler of nitric oxide synthase, has gained attention as a risk factor for cardiac disease, metabolic syndrome, and cerebrovascular disease. In this study, we investigated the role of systemic ADMA overburden in cerebromicrovascular pathology associated with cognitive dysfunction using APPSwDI transgenic mice expressing human β-amyloid precursor protein Swedish (Tg-SwDI), a model of cerebrovascular β-amyloidosis. To induce systemic overburden of ADMA, Tg-SwDI mice were treated with a daily dose of exogenous ADMA. ADMA treatment resulted in elevated ADMA levels in the blood and brain of Tg-SwDI mice. ADMA treatment induced the brain nitrosative stress and inflammation as well as enhanced the brain Aβ deposition and cognitive impairment in Tg-SwDI mice. However, ADMA treatment had no such effects on wild type mice. ADMA treatment also exacerbated brain microvascular pathology in Tg-SwDI mice as observed by increased blood-brain barrier dysfunction, loss of tight junction proteins, increased endothelial stress fibers, and decreased microvessel density in the brain. In addition, similar observations were made in cultured human brain microvessel endothelial cells, where ADMA in the presence of VEGF-induced endothelial cell signaling for F-actin stress fiber inducing endothelial barrier dysfunction. Overall, these data document the potential role of ADMA in the cognitive pathology under conditions of cerebrovascular β-amyloidosis.

摘要

不对称二甲基精氨酸(ADMA)是一种内源性的一氧化氮合酶抑制剂和解偶联剂,已成为心脏病、代谢综合征和脑血管病的危险因素。在这项研究中,我们使用表达人类β-淀粉样前体蛋白瑞典突变(Tg-SwDI)的 APPsweDI 转基因小鼠研究了系统性 ADMA 过载在与认知功能障碍相关的脑微血管病理学中的作用,Tg-SwDI 是一种脑血管β-淀粉样蛋白病的模型。为了诱导 ADMA 的系统性过载,Tg-SwDI 小鼠接受外源性 ADMA 的每日剂量治疗。ADMA 处理导致 Tg-SwDI 小鼠的血液和大脑中的 ADMA 水平升高。ADMA 处理诱导脑硝化应激和炎症,以及增强 Tg-SwDI 小鼠的脑 Aβ 沉积和认知障碍。然而,ADMA 处理对野生型小鼠没有这种作用。ADMA 处理还加剧了 Tg-SwDI 小鼠的脑微血管病理学,如血脑屏障功能障碍增加、紧密连接蛋白丢失、内皮应激纤维增加和脑微血管密度降低。此外,在培养的人脑微血管内皮细胞中也观察到类似的观察结果,其中 ADMA 在 VEGF 存在下诱导内皮细胞信号转导,导致 F-肌动蛋白应激纤维诱导内皮屏障功能障碍。总的来说,这些数据证明了 ADMA 在脑血管β-淀粉样蛋白病情况下认知病理学中的潜在作用。

相似文献

1
Asymmetric dimethylarginine exacerbates cognitive dysfunction associated with cerebrovascular pathology.非对称性二甲基精氨酸加剧与脑血管病变相关的认知功能障碍。
FASEB J. 2020 May;34(5):6808-6823. doi: 10.1096/fj.201901318R. Epub 2020 Apr 2.
2
Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.不对称二甲基精氨酸在内皮型一氧化氮合酶缺陷小鼠中产生血管病变:肾素-血管紧张素系统和氧化应激的参与
Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1682-8. doi: 10.1161/01.ATV.0000136656.26019.6e. Epub 2004 Jun 24.
3
Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine.抑制 eNOS 磷酸化介导肾衰竭中的内皮功能障碍:非对称性二甲基精氨酸的新作用。
Kidney Int. 2012 Apr;81(8):762-8. doi: 10.1038/ki.2011.476. Epub 2012 Feb 1.
4
Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.阿尔茨海默病患者血浆中同型半胱氨酸和不对称二甲基精氨酸浓度升高,一氧化氮浓度降低。
Neurobiol Aging. 2003 Nov;24(7):903-7. doi: 10.1016/s0197-4580(03)00007-1.
5
Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer's Disease.在阿尔茨海默病的Tg-SwDI小鼠模型中存在β淀粉样蛋白清除受损和脑微血管功能障碍。
Neuroscience. 2020 Aug 1;440:48-55. doi: 10.1016/j.neuroscience.2020.05.024. Epub 2020 May 23.
6
Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.内源性一氧化氮合酶抑制剂非对称二甲基精氨酸对人类冠状动脉疾病中内皮祖细胞的抑制作用。
J Am Coll Cardiol. 2005 Nov 1;46(9):1693-701. doi: 10.1016/j.jacc.2005.04.066. Epub 2005 Oct 10.
7
Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.不对称二甲基精氨酸是一氧化氮合酶的内源性抑制剂,在患有高同型半胱氨酸血症或高胆固醇血症的猴子中,其血浆浓度会升高。
Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1557-64. doi: 10.1161/01.atv.20.6.1557.
8
Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis.非对称性二甲基精氨酸(ADMA)通过涉及胶原和 TGF-β1 合成的机制诱导慢性肾脏病。
J Pathol. 2011 Jan;223(1):37-45. doi: 10.1002/path.2769. Epub 2010 Sep 15.
9
Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury.二甲基精氨酸二甲胺水解酶促进血管损伤后的内皮修复。
J Am Coll Cardiol. 2007 Mar 13;49(10):1099-105. doi: 10.1016/j.jacc.2006.10.068. Epub 2007 Feb 23.
10
Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats.不对称二甲基精氨酸(ADMA)可诱导大鼠血管内皮损伤,并加重缺血后心室功能障碍。
Eur J Pharmacol. 2007 Feb 28;557(2-3):178-85. doi: 10.1016/j.ejphar.2006.11.034. Epub 2006 Nov 22.

引用本文的文献

1
Protein Arginine Methyltransferases from Regulatory Function to Clinical Implication in Central Nervous System.从调节功能到中枢神经系统临床意义的蛋白质精氨酸甲基转移酶
Cell Mol Neurobiol. 2025 May 14;45(1):41. doi: 10.1007/s10571-025-01546-0.
2
Impact of Alterations in Homocysteine, Asymmetric Dimethylarginine and Vitamins-Related Pathways in Some Neurodegenerative Diseases: A Narrative Review.同型半胱氨酸、不对称二甲基精氨酸及维生素相关通路改变在某些神经退行性疾病中的影响:一项叙述性综述
Int J Mol Sci. 2025 Apr 13;26(8):3672. doi: 10.3390/ijms26083672.
3
Metabolomics and machine learning approaches for diagnostic biomarkers screening in systemic light chain amyloidosis.
用于系统性轻链淀粉样变性病诊断生物标志物筛选的代谢组学和机器学习方法
Ann Hematol. 2025 Mar;104(3):1669-1678. doi: 10.1007/s00277-025-06302-4. Epub 2025 Mar 13.
4
Asymmetric dimethylarginine induces maladaptive function of the blood-brain barrier.不对称二甲基精氨酸诱导血脑屏障的适应不良功能。
Front Cell Dev Biol. 2024 Oct 9;12:1476386. doi: 10.3389/fcell.2024.1476386. eCollection 2024.
5
Mammalian Models in Alzheimer's Research: An Update.阿尔茨海默病研究中的哺乳动物模型:更新。
Cells. 2023 Oct 16;12(20):2459. doi: 10.3390/cells12202459.
6
Critical Roles of Protein Arginine Methylation in the Central Nervous System.蛋白质精氨酸甲基化在中枢神经系统中的关键作用。
Mol Neurobiol. 2023 Oct;60(10):6060-6091. doi: 10.1007/s12035-023-03465-x. Epub 2023 Jul 6.
7
Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer's disease.精氨酸甲基转移酶 4 调节阿尔茨海默病中的一氧化氮合酶解偶联和脑血流。
J Cell Physiol. 2024 Jun;239(6):e30858. doi: 10.1002/jcp.30858. Epub 2022 Aug 29.
8
Multi-Omics Analysis Reveals Aberrant Gut-Metabolome-Immune Network in Schizophrenia.多组学分析揭示精神分裂症中肠道代谢组-免疫网络的异常
Front Immunol. 2022 Mar 3;13:812293. doi: 10.3389/fimmu.2022.812293. eCollection 2022.
9
Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.阿尔茨海默病中的血脑屏障渗漏:从发现到临床相关性。
Pharmacol Ther. 2022 Jun;234:108119. doi: 10.1016/j.pharmthera.2022.108119. Epub 2022 Jan 30.
10
Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation.机械力促进二甲基精氨酸二甲氨基水解酶 1 介导的代谢物不对称二甲基精氨酸的水解,从而增强骨形成。
Nat Commun. 2022 Jan 10;13(1):50. doi: 10.1038/s41467-021-27629-2.